ZOLFIGOL ET AL.
9 of 11
4‐(4‐Chlorophenyl)‐2,6‐bis(4‐methoxyphenyl)pyridine
133.81, 131.40, 126.65, 119.11, 110.76, 110.02, 54.98,
50.37, 31.95, 31.38, 29.31, 25.85.
(1f). M.p. 114–115 °C. FT‐IR (KBr, ν, cm−1): 2962, 1656,
1
1605, 1511, 1492, 1177, 817. H NMR (400 MHz, DMSO,
9‐(3‐Ethoxy‐4‐hydroxyphenyl)‐3,3,6,6‐tetramethyl‐
3,4,6,7,9,10‐hexahydroacridine‐1,8‐(2H,5H)‐dione (2i). M.
p. 282–284 °C. FT‐IR (KBr, ν, cm−1): 3276, 2966, 1646,
1620, 1478, 1365, 1221, 1144. 1H NMR (400 MHz, DMSO,
δ, ppm): 9.32 (s, 1H, NH), 8.60 (s, 1H, OH), 6.80–6.64 (m,
3H, aromatic), 4.82 (s, 1H, CH), 4.00 (br s, 2H, OCH2),
2.61–2.12 (m, 8H, CH2), 1.39 (br s, 3H, Me), 1.12 (s, 6H,
Me), 1.00 (s, 6H, Me). 13C NMR (101 MHz, DMSO, δ,
ppm): 194.43, 148.93, 145.72, 144.67, 138.40, 63.79, 50.30,
32.08, 31.81, 29.14, 26.34, 14.75.
δ, ppm): 8.23 (d, 2H, J = 8 Hz, aromatic), 8.05–7.97 (m,
4H, aromatic), 7.75 (d, 2H, J = 8 Hz, aromatic), 7.58 (d,
3H, J = 8 Hz, aromatic), 7.15 (d, 3H, J = 8 Hz, aromatic),
3.93 (s, 6H, OMe). 13C NMR (101 MHz, DMSO, δ, ppm):
187.2, 163.3, 141.6, 134.8, 133.8, 131.0, 130.4, 130.3,
128.9, 122.8, 114.0, 55.6.
4‐(4‐Methoxyphenyl)‐2,6‐di‐p‐tolylpyridine (1j). M.p.
183–185 °C. FT‐IR (KBr, ν, cm−1): 3061, 1609, 1597,
1509, 1424, 1180, 820. 1H NMR (400 MHz, DMSO, δ,
ppm): 8.27 (d, 4H, J = 8 Hz, aromatic), 8.13 (s, 2H, aro-
matic), 8.06 (d, 2H, J = 8 Hz, aromatic), 7.40 (d, 4H,
J = 8 Hz, aromatic), 7.16 (d, 2H, J = 8 Hz, aromatic),
3.90 (s, 3H, OMe), 2.44 (s, 6H, Me). 13C NMR (101 MHz,
DMSO, δ, ppm): 160.3, 156.3, 148.9, 138.6, 136.2, 130.7,
129.9, 129.3, 128.6, 126.8, 115.2, 114.4, 55.3, 20.9.
2,4,6‐Tris(4‐methoxyphenyl)pyridine (1k). M.p. 123–
127 °C. FT‐IR (KBr, ν, cm−1): 3003, 2836, 1608, 1583,
1509, 1427, 1174, 822. 1H NMR (400 MHz, DMSO, δ,
ppm): 8.33 (d, 4H, J = 8 Hz, aromatic), 8.07–8.04 (m,
4H, aromatic), 7.16 (t, 6H, J = 16 Hz, aromatic), 3.91 (s,
9H, OMe). 13C NMR (101 MHz, DMSO, δ, ppm): 160.2,
155.9, 148.8, 131.5, 130.1, 128.5, 128.2, 114.4, 114.3,
114.0, 55.2.
4′‐(4‐Chlorophenyl)‐2,2′:6′,2″‘‐terpyridine (1n). M.p.
160–164 °C. FT‐IR (KBr, ν, cm−1): 3058, 1602, 1583,
1549, 1471, 1091, 786. 1H NMR (400 MHz, DMSO, δ,
ppm): 9.09 (s, 1H, aromatic), 8.81–8.63 (m, 4H, aromatic),
8.38 (s, 3H, aromatic), 8.02 (s, 2H, aromatic), 7.62–7.53
(m, 4H, aromatic). 13C NMR (101 MHz, DMSO, δ, ppm):
155.9, 155.2, 155.0, 153.4, 149.9, 149.3, 148.1, 137.6,
137.4, 137.2, 134.2, 129.3, 128.8, 128.6, 124.5, 124.5,
121.5, 120.9, 120.8, 117.8, 117.3, 116.5.
9‐(3,5‐Difluorophenyl)‐3,3,6,6‐tetramethyl‐
3,4,6,7,9,10‐hexahydroacridine‐1,8‐(2H,5H)‐dione (2l). M.
p. 301–303 °C. FT‐IR (KBr, ν, cm−1): 3277, 2961, 1646,
1
1619, 1488, 1365, 1222, 1144, 987. H NMR (400 MHz,
DMSO, δ, ppm): 9.45 (s, 1H, NH), 6.91–6.79 (m, 3H, aro-
matic), 4.89 (s, 1H, CH), 2.45–2.13 (m, 8H, CH2), 1.00 (s,
6H, Me), 0.92 (s, 6H, Me). 13C NMR (101 MHz, DMSO,
δ, ppm): 194.45, 163.13, 160.71, 151.39, 150.01, 110.50,
110.27, 101.07, 50.05, 33.14, 32.12, 28.88, 26.44.
9‐(4‐Methoxyphenyl)‐3,3,6,6‐tetramethyl‐3,4,6,7,9,10‐
hexahydroacridine‐1,8‐(2H,5H)‐dione
(2o).
M.p.
269–271 °C. FT‐IR (KBr, ν, cm−1): 3279, 2958, 1644, 1634,
1606, 1483, 1368, 1145, 834. 1H NMR (400 MHz, DMSO, δ,
ppm): 9.25 (s, 1H, NH), 7.06–6.73 (m, 4H, aromatic), 4.77
(s, 1H, CH), 3.67 (s, 3H, OMe), 2.19–2.02 (m, 8H, CH2),
1.00 (s, 6H, Me), 0.90 (s, 6H, Me). 13C NMR (101 MHz,
DMSO, δ, ppm): 194.34, 157.06, 149.00, 139.49, 128.49,
112.89, 111.67, 54.79, 50.25, 32.10, 31.86, 29.09, 26.47.
3,3,6,6‐Tetramethyl‐9‐(thiophen‐2‐yl)‐3,4,6,7,9,10‐
hexahydroacridine‐1,8‐(2H,5H)‐dione
(2q).
M.p.
313–315 °C. FT‐IR (KBr, ν, cm−1): 3277, 2956, 1638,
1
1626, 1605, 1482, 1371, 1217, 716. H NMR (400 MHz,
DMSO, δ, ppm): 9.25 (s, 1H, NH), 6.95–6.55 (m, 3H,
aromatic), 4.95 (s, 1H, CH), 2.01–2.28 (m, 8H, CH2), 0.76
(s, 12H, Me). 13C NMR (101 MHz, DMSO, δ, ppm):
194.3, 192.4, 149.6, 126.2, 123.0, 122.8, 110.8, 50.2, 32.7,
32.42, 28.78, 27.1, 26.5.
9‐(3‐Hydroxy‐4‐methylphenyl)‐3,3,6,6‐tetramethyl‐
3,4,6,7,9,10‐hexahydroacridine‐1,8‐(2H,5H)‐dione
(2d).
M.p. 317–319 °C. FT‐IR (KBr, ν, cm−1): 3538, 2958, 1650,
1
1607, 1489, 1367, 1143, 759. H NMR (400 MHz, DMSO,
δ, ppm): 8.99 (s, 1H, NH), 8.38 (s, 1H, OH), 6.43–6.29
(m, 3H, aromatic), 4.45 (s, 1H, CH), 3.12 (s, 3H, Me),
2.25–1.77 (m, 8H, CH2), 0.76 (s, 6H, Me), 0.66 (s, 6H,
Me). 13C NMR (101 MHz, DMSO, δ, ppm): 194.33,
148.88, 145.53, 140.12, 118.05, 115.47, 111.69, 111.47,
55.50, 50.31, 32.09, 31.82, 29.10, 26.57.
9‐(2‐Methoxyphenyl)‐3,3,6,6,tetramethyl‐3,4,6,7,9,10‐
hexahydroacridine‐1,8‐(2H,5H)‐dione (2e). M.p. 298–
300 °C. FT‐IR (KBr, ν, cm−1): 3285, 2955, 1645, 1605,
1489, 1224, 1143, 747. 1H NMR (400 MHz, DMSO, δ,
ppm): 8.97 (s, 1H, NH), 6.94–6.56 (m, 4H, aromatic),
4.69 (s, 1H, CH), 3.43 (s, 3H, OMe), 2.26–1.66 (m, 8H,
CH2), 0.76 (s, 6H, Me), 0.58 (s, 6H, Me). 13C NMR
(101 MHz, DMSO, δ, ppm): 194.02, 157.57, 149.59,
ACKNOWLEDGEMENTS
We thank Bu‐Ali Sina University and Iran National Sci-
ence Foundation (INSF) (The grant Number: 95831207)
and National Elites Foundation for financial support to
our research groups.
ORCID